Mania

Mania is a state of abnormally elevated mood, energy, and arousal marked by racing thoughts, reduced need for sleep, and impaired judgment.

As a drug effect it is acute and dose-proportional, fading as the substance wears off, which sets it apart from the manic episodes of bipolar disorder. It ranges from mild overconfidence and pressured speech to severe agitation, grandiosity, and disorganized thought, and can escalate into reckless behavior or frank psychosis.

Drug-induced mania is rare. It is most commonly induced at high doses under dissociatives such as ketamine, 3-MeO-PCP, and 3-HO-PCE, and under stimulants such as amphetamine, cocaine, and desoxypipradrol. It also appears, less predictably, under depressants like pregabalin and zolpidem, typically during acute intoxication rather than rebound.

Mania is felt as a surge of energy that outpaces any capacity to direct it: thoughts arrive faster than they can be spoken, attention shifts rapidly without settling, and confidence in one's own abilities expands beyond what evidence supports.

It commonly comes with a reduced need for sleep without fatigue, pressured speech, and heightened physical restlessness. The elevated state tends to feel self-confirming — the sense of being exceptional seems like proof that it is true. At high doses, particularly under dissociatives, it can tip into grandiose delusion or frank psychotic disorganization.

Mania arises through different pathways depending on the drug class:

• Dissociatives — block NMDA receptors, disrupting inhibitory control and producing disinhibited arousal; 3-MeO-PCP and related compounds carry particularly high manic liability, likely through additional monoaminergic activity.
• Stimulants — flood the synapse with dopamine and noradrenaline; at high doses the resulting arousal escalates beyond euphoria into uncontrolled activation.
• Depressants — pregabalin and zolpidem can trigger manic states during intoxication through mechanisms that remain poorly characterized.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses raise both likelihood and intensity across all classes. A personal or family history of bipolar disorder substantially increases risk, as does sleep deprivation going in.

Dissociatives carry the highest intrinsic manic liability; stimulants become riskier with prolonged use or binge patterns. An already elevated or agitated mood prior to use tends to be self-reinforcing. Lower doses and adequate sleep before use reduce the risk considerably.